Catalyst Pharmaceuticals, Inc. Share Price
Stocks
CPRX
US14888U1016
Pharmaceuticals
|
Market Closed -
Nasdaq
01:30:00 15/07/2026 am IST
|
5-day change | 1st Jan Change | ||
| 31.49 USD | +0.03% |
|
-.--% | +34.92% |
| 03/08 | CDP targets new defense acquisitions after T-Defence deal - sources | RE |
| 03/08 | CDP's new chapter, a push for global companies | AN |
| Market Cap | 385.5Cr 330.37Cr 309.07Cr 282.56Cr 533.22Cr 37TCr 538.89Cr 3.66TCr 1.42TCr 19TCr 1.45TCr 1.42TCr 61TCr | P/E 2024 |
15.9x | P/E 2025 | 13.9x |
|---|---|---|---|---|---|
| Enterprise Value | 314.86Cr 269.84Cr 252.43Cr 230.79Cr 435.51Cr 30TCr 440.14Cr 2.99TCr 1.16TCr 15TCr 1.18TCr 1.16TCr 50TCr | EV / Sales 2024 |
4.02x | EV / Sales 2025 | 3.67x |
| Free-Float |
99.94% | Yield 2024 * |
-
| Yield 2025 | - |
Last Transcript: Catalyst Pharmaceuticals, Inc.
| 1 day | +0.03% | ||
| 3 months | +0.74% | ||
| 6 months | +30.18% | ||
| Current year | +34.92% |
| Current year | 22.13 |  | 32.56 |
| 1 year | 19.05 | | 32.56 |
| 3 years | 11.55 | | 32.56 |
| 5 years | 4.81 | | 32.56 |
| 10 years | 0.94 | | 32.56 |
| Manager | Title | Age | Since |
|---|---|---|---|
Richard Daly
CEO | Chief Executive Officer | 65 | 01/01/2024 |
Michael Kalb
DFI | Director of Finance/CFO | 55 | 01/01/2024 |
William Andrews
CTO | Chief Tech/Sci/R&D Officer | 62 | 01/06/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 48 | 15/07/2026 | |
Massimo Marin
BRD | Director/Board Member | - | 15/07/2026 |
Enrica Dogali
BRD | Director/Board Member | - | 15/07/2026 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 15/07/26 | Issuer sale | Director | -63,583 | 0.0519% | ||
| 15/07/26 | Issuer sale | Director | -1,30,857 | 0.1069% | ||
| 15/07/26 | Issuer sale | Executive/Senior Manager | -10,51,183 | 0.8587% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.03% | -.--% | +49.38% | +127.36% | 385.5Cr | |
| -0.66% | +2.80% | +40.55% | -0.33% | 8.33TCr | |
| -4.30% | +115.47% | +412.13% | +23.29% | 5.79TCr | |
| +3.25% | +10.59% | -19.35% | -33.74% | 5.78TCr | |
| +1.42% | +1.61% | -0.67% | +34.08% | 5.17TCr | |
| -0.77% | +2.14% | +11.51% | +170.00% | 4.93TCr | |
| +0.62% | +4.29% | +56.57% | -16.88% | 3.2TCr | |
| +0.13% | +3.63% | +50.49% | +99.25% | 2.59TCr | |
| +1.51% | +4.50% | +1.05% | +198.82% | 2.27TCr | |
| -1.74% | -1.27% | +55.54% | +107.91% | 1.69TCr | |
| Average | -0.05% | +16.70% | +65.72% | +70.98% | 4.01TCr | |
| Weighted average by Cap. | -0.14% | +22.42% | +77.07% | +45.80% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 49Cr 42Cr 39Cr 36Cr 68Cr 4.71TCr 69Cr 466.5Cr 181.4Cr 2.36TCr 184.63Cr 180.63Cr 7.82TCr | 59Cr 50Cr 47Cr 43Cr 81Cr 5.64TCr 82Cr 558.77Cr 217.27Cr 2.83TCr 221.15Cr 216.36Cr 9.37TCr |
| Net income | 16Cr 14Cr 13Cr 12Cr 23Cr 1.57TCr 23Cr 155.48Cr 60Cr 788Cr 62Cr 60Cr 2.61TCr | 21Cr 18Cr 17Cr 16Cr 30Cr 2.05TCr 30Cr 203.33Cr 79Cr 1.03TCr 80Cr 79Cr 3.41TCr |
| Net Debt | -51Cr -44Cr -41Cr -38Cr -71Cr -4.93TCr -72Cr -487.97Cr -189.74Cr -2.47TCr -193.13Cr -188.95Cr -8.18TCr | -71Cr -61Cr -57Cr -52Cr -98Cr -6.76TCr -99Cr -670.14Cr -260.58Cr -3.4TCr -265.23Cr -259.48Cr -11TCr |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- CPRX Stock
Select your edition
All financial news and data tailored to specific country editions
